NCT00581607 - Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions

SarcoidosisPulmonary Arterial Hypertension

Interventions

DRUG

Bosentan

62.5 mg bid for 4 weeks, then 125 mg bid

DRUG

Placebo

Placebo twice a day

DRUG

Bosentan

drug given for 16 weeks

DRUG

Placebo

placebo

Trial Locations (4)

University of Cincinnati, Cincinnati

Mount Sinai, New York

Cleveland Clinic, Cleveland

University of Pittsburgh, Pittsburgh